Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065767
Status:
COMPLETED
Last Update Posted:
2015-10-05
First Post:
2003-07-31
Brief Title:
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimers Disease
Sponsor:
University of Wisconsin Madison
Organization:
University of Wisconsin Madison
Study Overview
Official Title:
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to determine the effectiveness of treatment with raloxifene an estrogen-like medication approved by the Food and Drug Administration for the treatment of osteoporosis in improving memory and the ability to live independently in postmenopausal women with Alzheimers disease
Detailed Description:
The aim of this study is to determine the effectiveness of treatment with raloxifene an estrogen-like medication classified as Selective Estrogen Receptor Modulators SERs approved by the Food and Drug Administration for the treatment of osteoporosis in improving memory and the ability to live independently in postmenopausal women with Alzheimers disease Patients who volunteer for this study will need to visit the clinic 7 times participate over a period of five months and will receive either raloxifene or a harmless inactive pill called a placebo Neither the volunteers nor the study staff will know which type of pill a patient receives Patients must be generally healthy and have mild-to-moderate dementia There must be a patient caregiver who can watch for side effects and ensure that the patient takes the study pills on schedule over a period of three months
Patients will undergo neuropsychological tests and an evaluation of the ability to live independently at each visit as well as laboratory evaluations such as the taking of blood Each visit will last approximately 3 hours A total of 20 patients is being recruited to participate in this study at the University of Wisconsin
Patients will undergo neuropsychological tests and an evaluation of the ability to live independently at each visit as well as laboratory evaluations such as the taking of blood Each visit will last approximately 3 hours A total of 20 patients is being recruited to participate in this study at the University of Wisconsin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R01AG029624-01 | NIH | None | None |
| IRB M1285 | US NIH GrantContract | None | httpsreporternihgovquickSearch1R01AG029624-01 |